← Eichor
Condition: Schizoaffective Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Schizoaffective

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Phase 4 · 1 location(s) · Corporal Michael J. Crescenz VA Medical Center · NCT03495024
MicroRNAs as Biomarkers in First Episode Schizophrenia
NA · 1 location(s) · Northwell Health · NCT07703670
Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
Phase 3 · 1 location(s) · Louisiana State University Health Sciences Center Shreveport · NCT06482554
Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
NA · 1 location(s) · Mclean Hospital · NCT06221852
Enhancing Rehabilitation for Veterans With Serious Mental Illness
NA · 1 location(s) · VA Office of Research and Development · NCT06586164
Cerebellar Modulation of Cognition in Psychosis
NA · 2 location(s) · Mclean Hospital · NCT06107764
Database Registry for Neural Network Biomarkers in Psychosis
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT01409109
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Phase 1/Phase 2 · 1 location(s) · Vishwajit Nimgaonkar, MD PhD · NCT03794076
Magnetic Seizure Therapy for Schizophrenia - Trial
NA · 2 location(s) · Centre for Addiction and Mental Health · NCT06672588
Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Anal
NA · 1 location(s) · Shanghai Mental Health Center · NCT06904079
40 Hz Visual Stimulation as an Intervention in Schizophrenia
NA · 1 location(s) · Technical University of Munich · NCT06907420
Anticholinergic Deprescription in Schizophrenia
Phase 4 · 1 location(s) · Deepak K. Sarpal, M.D. · NCT06562608
The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receivi
NA · 1 location(s) · DINA KEUMALA SARI · NCT07696000
Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)
NA · 1 location(s) · University of California, San Diego · NCT06865937
Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizop
NA · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT07058389
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Sympt
Phase 4 · 22 location(s) · Neurocrine Biosciences · NCT07105111
Synbiotic Compound to Reduce Symptoms of Schizophrenia
Phase 2 · 1 location(s) · Sheppard Pratt Health System · NCT04226898
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
NA · 1 location(s) · University of California, Los Angeles · NCT05890183
Transition Care for FEP
Phase N/A · 2 location(s) · University of Chicago · NCT07713849
Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine
NA · 1 location(s) · Deepak K. Sarpal, M.D. · NCT06003036
Enhanced Coordinated Specialty Care for Early Psychosis
NA · 5 location(s) · Mclean Hospital · NCT06071858
Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination
NA · 1 location(s) · National Institute of Mental Health and Neuro Sciences, Indi · NCT04629352
Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia
Phase N/A · 1 location(s) · Centre for Addiction and Mental Health · NCT05435300
Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness
NA · 1 location(s) · VA Office of Research and Development · NCT05157620
Cognitive Strategies in Early Psychosis 2
Phase 3 · 1 location(s) · University of Minnesota · NCT07263022
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
Phase 4 · 1 location(s) · Centre for Addiction and Mental Health · NCT02639702
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
NA · 3 location(s) · University of California, San Diego · NCT07098169
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Phase N/A · 6 location(s) · Beth Israel Deaconess Medical Center · NCT06740383
Effectiveness of Motivation Skills Training (MST)
NA · 2 location(s) · Columbia University · NCT05805397
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT05064319
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.